About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ulcerative Colitis Clinical Trials in Houston | 47 Studies

Clinical Trials Ulcerative ColitisHouston

Ulcerative Colitis Clinical Trials in Houston

Find 47 clinical trials for ulcerative colitis near Houston, Texas. Connect with research centers in your area.

All Ulcerative Colitis trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-47 of 47 trials

RecruitingA Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies.NCT05442567·Mobile, Alabama and 97 others

Ulcerative Colitis Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Enrolling by invitationUtility of Random Biopsies in Patients With Inflammatory Bowel DiseaseThe proposed study is a multicenter parallel group clinical trial that will include 821 evaluable patients per group who will be randomly assigned to either high definition white…NCT06560021·Birmingham, Alabama and 20 others

TerminatedTD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) StudyA 3-Year Multi-Center, Long-Term Safety (LTS) Study to Evaluate the Safety and Tolerability of TD-1473 in Subjects with Ulcerative Colitis who have participated in the Maintenance…NCT03920254·Chula Vista, California and 183 others

CompletedA Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative ColitisThe objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo in inducing clinical remission (per Adapted Mayo score) in participants with…NCT03653026·Mobile, Alabama and 378 others

CompletedA Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative ColitisThe objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active…NCT03398148·Coronado, California and 429 others

TerminatedEfficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisThe purpose of this study is to evaluate the efficacy of SHP647 in inducing remission, based on composite score of patient-reported symptoms and centrally read endoscopy, in…NCT03259308·Mesa, Arizona and 206 others

CompletedTD-1473 for Active Ulcerative Colitis (UC)This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TD-1473 in subjects with moderately-to-severely active UC over 28…NCT02818686·Scottsdale, Arizona and 7 others

PreviousPage 3 of 3

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia